AcelRx Pharmaceuticals' Series B Round

AcelRx Pharmaceuticals raised a round of funding on February 18, 2009.

AcelRx Pharmaceuticals is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of acute and breakthrough pain. AcelRx's lead product candi…

Articles about AcelRx Pharmaceuticals' Series B Round: